A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects

NCT00449527 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Budesonide/formoterol pMDI
DRUG: Budesonide HFA pMDI

Sponsor

AstraZeneca